- call +1-201-465-4211
- email sales@mrinsights.biz
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.
Scope of the Report:
Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
The classification of Medical Asparaginase includes Escherichia coli, Erwinia Chrysanthemi and Pegylated, and the sales proportion of Escherichia coli in 2017 is about 64.6%, and the proportion is decreasing trend from 2013 to 2018.
Medical Asparaginase is widely sales for Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia and Others. The most proportion of Medical Asparaginase is sales in Acute Lymphoblastic Leukemia, and the consumption proportion is about 90% in 2017.
North America is the largest consumption place, with a revenue market share nearly 53.5% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 37.2%, China is also an important sales region for the Medical Asparaginase, In China, the price is lower than the developed countries.
Market competition is intense. Jazz Pharmaceuticals, Shire, Medac GmbH, Kyowa Hakko Kirin, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
The worldwide market for Medical Asparaginase is expected to grow at a CAGR of roughly 1.5% over the next five years, will reach 430 million US$ in 2024, from 390 million US$ in 2019, according to a new study.
This report focuses on the Medical Asparaginase in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Jazz Pharmaceuticals
Shire
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Escherichia coli
Erwinia Chrysanthemi
Pegylated
Market Segment by Applications, can be divided into
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Asparaginase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Medical Asparaginase, with price, sales, revenue and global market share of Medical Asparaginase in 2017 and 2018.
Chapter 3, the Medical Asparaginase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Asparaginase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Medical Asparaginase market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Medical Asparaginase sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Medical Asparaginase Introduction
1.2 Market Analysis by Type
1.2.1 Escherichia coli
1.2.2 Erwinia Chrysanthemi
1.2.3 Pegylated
1.3 Market Analysis by Applications
1.3.1 Acute Lymphoblastic Leukemia
1.3.2 Acute Myeloid Leukemia
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Jazz Pharmaceuticals
2.1.1 Business Overview
2.1.2 Medical Asparaginase Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Jazz Pharmaceuticals Medical Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Shire
2.2.1 Business Overview
2.2.2 Medical Asparaginase Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shire Medical Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Medac GmbH
2.3.1 Business Overview
2.3.2 Medical Asparaginase Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medac GmbH Medical Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Kyowa Hakko Kirin
2.4.1 Business Overview
2.4.2 Medical Asparaginase Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Kyowa Hakko Kirin Medical Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Qianhong Bio-pharma
2.5.1 Business Overview
2.5.2 Medical Asparaginase Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Qianhong Bio-pharma Medical Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Taj Pharmaceuticals
2.6.1 Business Overview
2.6.2 Medical Asparaginase Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Taj Pharmaceuticals Medical Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Mingxing Pharma
2.7.1 Business Overview
2.7.2 Medical Asparaginase Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mingxing Pharma Medical Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 SL Pharma
2.8.1 Business Overview
2.8.2 Medical Asparaginase Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 SL Pharma Medical Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 United Biotech
2.9.1 Business Overview
2.9.2 Medical Asparaginase Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 United Biotech Medical Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Medical Asparaginase Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Medical Asparaginase Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Medical Asparaginase Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Medical Asparaginase Manufacturer Market Share in 2018
3.3.2 Top 6 Medical Asparaginase Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Medical Asparaginase Market Analysis by Regions
4.1 Global Medical Asparaginase Sales, Revenue and Market Share by Regions
4.1.1 Global Medical Asparaginase Sales and Market Share by Regions (2014-2019)
4.1.2 Global Medical Asparaginase Revenue and Market Share by Regions (2014-2019)
4.2 North America Medical Asparaginase Sales and Growth Rate (2014-2019)
4.3 Europe Medical Asparaginase Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Medical Asparaginase Sales and Growth Rate (2014-2019)
4.5 South America Medical Asparaginase Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Medical Asparaginase Sales and Growth Rate (2014-2019)
5 North America Medical Asparaginase by Country
5.1 North America Medical Asparaginase Sales, Revenue and Market Share by Country
5.1.1 North America Medical Asparaginase Sales and Market Share by Country (2014-2019)
5.1.2 North America Medical Asparaginase Revenue and Market Share by Country (2014-2019)
5.2 United States Medical Asparaginase Sales and Growth Rate (2014-2019)
5.3 Canada Medical Asparaginase Sales and Growth Rate (2014-2019)
5.4 Mexico Medical Asparaginase Sales and Growth Rate (2014-2019)
6 Europe Medical Asparaginase by Country
6.1 Europe Medical Asparaginase Sales, Revenue and Market Share by Country
6.1.1 Europe Medical Asparaginase Sales and Market Share by Country (2014-2019)
6.1.2 Europe Medical Asparaginase Revenue and Market Share by Country (2014-2019)
6.2 Germany Medical Asparaginase Sales and Growth Rate (2014-2019)
6.3 UK Medical Asparaginase Sales and Growth Rate (2014-2019)
6.4 France Medical Asparaginase Sales and Growth Rate (2014-2019)
6.5 Russia Medical Asparaginase Sales and Growth Rate (2014-2019)
6.6 Italy Medical Asparaginase Sales and Growth Rate (2014-2019)
7 Asia-Pacific Medical Asparaginase by Country
7.1 Asia-Pacific Medical Asparaginase Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Medical Asparaginase Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Medical Asparaginase Revenue and Market Share by Country (2014-2019)
7.2 China Medical Asparaginase Sales and Growth Rate (2014-2019)
7.3 Japan Medical Asparaginase Sales and Growth Rate (2014-2019)
7.4 Korea Medical Asparaginase Sales and Growth Rate (2014-2019)
7.5 India Medical Asparaginase Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Medical Asparaginase Sales and Growth Rate (2014-2019)
8 South America Medical Asparaginase by Country
8.1 South America Medical Asparaginase Sales, Revenue and Market Share by Country
8.1.1 South America Medical Asparaginase Sales and Market Share by Country (2014-2019)
8.1.2 South America Medical Asparaginase Revenue and Market Share by Country (2014-2019)
8.2 Brazil Medical Asparaginase Sales and Growth Rate (2014-2019)
8.3 Argentina Medical Asparaginase Sales and Growth Rate (2014-2019)
8.4 Colombia Medical Asparaginase Sales and Growth Rate (2014-2019)
9 Middle East and Africa Medical Asparaginase by Countries
9.1 Middle East and Africa Medical Asparaginase Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Medical Asparaginase Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Medical Asparaginase Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Medical Asparaginase Sales and Growth Rate (2014-2019)
9.3 Turkey Medical Asparaginase Sales and Growth Rate (2014-2019)
9.4 Egypt Medical Asparaginase Sales and Growth Rate (2014-2019)
9.5 Nigeria Medical Asparaginase Sales and Growth Rate (2014-2019)
9.6 South Africa Medical Asparaginase Sales and Growth Rate (2014-2019)
10 Global Medical Asparaginase Market Segment by Type
10.1 Global Medical Asparaginase Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Medical Asparaginase Sales and Market Share by Type (2014-2019)
10.1.2 Global Medical Asparaginase Revenue and Market Share by Type (2014-2019)
10.2 Escherichia coli Sales Growth and Price
10.2.1 Global Escherichia coli Sales Growth (2014-2019)
10.2.2 Global Escherichia coli Price (2014-2019)
10.3 Erwinia Chrysanthemi Sales Growth and Price
10.3.1 Global Erwinia Chrysanthemi Sales Growth (2014-2019)
10.3.2 Global Erwinia Chrysanthemi Price (2014-2019)
10.4 Pegylated Sales Growth and Price
10.4.1 Global Pegylated Sales Growth (2014-2019)
10.4.2 Global Pegylated Price (2014-2019)
11 Global Medical Asparaginase Market Segment by Application
11.1 Global Medical Asparaginase Sales Market Share by Application (2014-2019)
11.2 Acute Lymphoblastic Leukemia Sales Growth (2014-2019)
11.3 Acute Myeloid Leukemia Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Medical Asparaginase Market Forecast (2019-2024)
12.1 Global Medical Asparaginase Sales, Revenue and Growth Rate (2019-2024)
12.2 Medical Asparaginase Market Forecast by Regions (2019-2024)
12.2.1 North America Medical Asparaginase Market Forecast (2019-2024)
12.2.2 Europe Medical Asparaginase Market Forecast (2019-2024)
12.2.3 Asia-Pacific Medical Asparaginase Market Forecast (2019-2024)
12.2.4 South America Medical Asparaginase Market Forecast (2019-2024)
12.2.5 Middle East and Africa Medical Asparaginase Market Forecast (2019-2024)
12.3 Medical Asparaginase Market Forecast by Type (2019-2024)
12.3.1 Global Medical Asparaginase Sales Forecast by Type (2019-2024)
12.3.2 Global Medical Asparaginase Market Share Forecast by Type (2019-2024)
12.4 Medical Asparaginase Market Forecast by Application (2019-2024)
12.4.1 Global Medical Asparaginase Sales Forecast by Application (2019-2024)
12.4.2 Global Medical Asparaginase Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Medical Asparaginase Picture
Table Product Specifications of Medical Asparaginase
Figure Global Sales Market Share of Medical Asparaginase by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
